US Stock MarketDetailed Quotes
TVTX Travere Therapeutic
- 9.650
- -0.150-1.53%
Close Jul 22 16:00 ET
734.65MMarket Cap-4849P/E (TTM)
10.170High9.410Low797.17KVolume9.900Open9.800Pre Close7.67MTurnover1.42%Turnover RatioLossP/E (Static)76.13MShares17.57052wk High9.92P/B541.40MFloat Cap5.12052wk Low--Dividend TTM56.10MShs Float37.040Historical High--Div YieldTTM7.76%Amplitude0.000Historical Low9.625Avg Price1Lot Size
Travere Therapeutic Key Stats
Quarterly+Annual
YOY
| (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 33.95%41.37M | 32.69%145.24M | 53.58%45.06M | 32.13%37.1M | 10.21%59.7M | -36.30%30.89M | -16.97%109.46M | 176.39%29.34M | -58.84%28.08M | -0.82%54.17M |
| Operating revenue | 33.95%41.37M | 32.69%145.24M | 53.58%45.06M | 32.13%37.1M | 10.21%59.7M | -36.30%30.89M | -16.97%109.46M | 176.39%29.34M | -58.84%28.08M | -0.82%54.17M |
| Cost of revenue | -63.72%1.5M | 159.05%11.45M | 425.81%4.56M | 15.71%1.29M | -2.97%1.99M | 93.87%4.15M | 15.77%4.42M | 181.12%868K | -30.03%1.11M | 24.23%2.05M |
| Gross profit | 49.09%39.87M | 27.37%133.79M | 42.23%40.5M | 32.81%35.81M | 10.73%57.71M | -42.30%26.74M | -17.95%105.04M | 176.26%28.47M | -59.53%26.96M | -1.60%52.12M |
| Operating expense | 44.10%178.85M | 20.17%510.53M | 7.09%123.33M | 17.18%128.39M | 27.33%143.45M | 20.03%124.11M | 29.75%424.85M | 61.14%115.17M | 29.71%109.57M | 29.83%112.66M |
| Selling and administrative expenses | -2.62%64.22M | 34.44%265.54M | 11.39%63.59M | 29.34%67.8M | 39.75%74.04M | 40.95%65.95M | 56.41%197.52M | 208.97%57.09M | 45.35%52.42M | 51.52%52.98M |
| -General and administrative expense | -2.62%64.22M | 34.44%265.54M | 11.39%63.59M | 29.34%67.8M | ---- | --65.95M | 56.41%197.52M | --57.09M | --52.42M | ---- |
| Research and development costs | 97.08%114.63M | 7.77%244.99M | 2.86%59.75M | 6.03%60.59M | 16.30%69.41M | 2.74%58.16M | 13.01%227.33M | 9.60%58.09M | 18.05%57.15M | 15.20%59.68M |
| Operating profit | -42.73%-138.98M | -17.80%-376.74M | 4.46%-82.84M | -12.08%-92.59M | -41.62%-85.74M | -70.67%-97.37M | -60.37%-319.81M | 20.32%-86.7M | -362.85%-82.6M | -79.09%-60.54M |
| Net non-operating interest income expense | 306.03%3.23M | 320.22%10.43M | 1,585.21%4.33M | 514.97%3.02M | 201.23%2.22M | 135.58%796K | 73.21%-4.74M | 105.88%257K | 83.96%-728K | 43.32%-2.19M |
| Non-operating interest income | 65.44%6.03M | 246.85%21.77M | 129.60%7.15M | 178.06%5.84M | 555.75%5.13M | 1,211.51%3.65M | 214.90%6.28M | 1,219.92%3.12M | 483.61%2.1M | -20.85%782K |
| Non-operating interest expense | -1.75%2.8M | 2.91%11.33M | -1.29%2.82M | -0.28%2.82M | -2.05%2.91M | 13.32%2.85M | -44.04%11.01M | -38.00%2.86M | -42.25%2.83M | -38.75%2.97M |
| Other net income (expense) | -124.14%-21K | -48.39%-9.8M | -1,249.08%-10.02M | 157.17%335K | 51.92%-2.04M | 100.52%87K | -2,958.87%-6.6M | -96.43%872K | 95.56%-586K | -228.31%-4.25M |
| Special income (charges) | ---259K | -50.36%-11.39M | ---11.39M | --0 | 62.50%-1.84M | --0 | ---7.58M | --0 | --0 | -225.18%-4.91M |
| -Less：Restructuring and merger&acquisition | --259K | --11.39M | ---- | ---- | -62.50%1.84M | --0 | --0 | ---- | ---- | 225.18%4.91M |
| -Less:Other special charges | ---- | ---- | ---- | ---- | ---- | ---- | --7.58M | --0 | ---- | ---- |
| Other non- operating income (expenses) | 173.56%238K | 63.66%1.59M | 57.57%1.37M | 157.17%335K | -130.36%-201K | 234.62%87K | 321.65%974K | 92.07%872K | -189.60%-586K | 206.48%662K |
| Income before tax | -40.71%-135.77M | -13.58%-376.11M | -3.45%-88.53M | -6.33%-89.23M | -27.75%-85.57M | -27.09%-96.49M | -52.69%-331.16M | 3.60%-85.57M | -135.75%-83.92M | -71.90%-66.98M |
| Income tax | 144.87%191K | -28.75%223K | 7.94%68K | -91.72%12K | 22.64%65K | 50.00%78K | -23.47%313K | 1,475.00%63K | 237.21%145K | 8.16%53K |
| Net income | -57.60%-136.06M | 60.00%-111.4M | -36.99%-90.17M | 316.40%150.74M | -27.74%-85.63M | -13.64%-86.33M | -54.63%-278.48M | -27.63%-65.82M | -95.45%-69.66M | -71.82%-67.03M |
| Net income continuous Operations | -40.80%-135.96M | -13.54%-376.33M | -3.46%-88.6M | -6.16%-89.24M | -27.74%-85.63M | -27.11%-96.56M | -52.54%-331.47M | 3.53%-85.64M | -135.87%-84.06M | -71.82%-67.03M |
| Net income discontinuous operations | -101.01%-103K | 400.01%264.93M | -107.96%-1.58M | 1,565.69%239.98M | ---- | --10.23M | 42.43%52.99M | --19.81M | --14.41M | ---- |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | -57.60%-136.06M | 60.00%-111.4M | -36.99%-90.17M | 316.40%150.74M | -27.74%-85.63M | -13.64%-86.33M | -54.63%-278.48M | -27.63%-65.82M | -95.45%-69.66M | -71.82%-67.03M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | -57.60%-136.06M | 60.00%-111.4M | -36.99%-90.17M | 316.40%150.74M | -27.74%-85.63M | -13.64%-86.33M | -54.63%-278.48M | -27.63%-65.82M | -95.45%-69.66M | -71.82%-67.03M |
| Basic earnings per share | -38.58%-1.76 | 65.68%-1.5 | -14.56%-1.18 | 280.73%1.97 | -7.62%-1.13 | -5.83%-1.27 | -45.18%-4.37 | -22.62%-1.03 | -84.75%-1.09 | -64.06%-1.05 |
| Diluted earnings per share | -38.58%-1.76 | 65.68%-1.5 | -14.56%-1.18 | 280.73%1.97 | -7.62%-1.13 | -5.83%-1.27 | -45.18%-4.37 | -22.62%-1.03 | -84.75%-1.09 | -64.06%-1.05 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg